BSE: ALKEM - Alkem Laboratories Limited

Yield per half year: -0.7031%
Dividend yield: +1.03%

Alkem Laboratories Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
31.91 45.31 -29.56% 28.72 +11.13%
P/S 4.61 5.02 -8.3%
P/BV 5.35 6.25 -14.46%
P/FCF 27.97 170.32 -83.58%
Ev/Ebitda 24.18 13.54 78.6%
Ev/S 4.67 4.73 -1.36%
Ev/FCF 34.39 165.19 -79.18%
E/P 0.038 0.0451 -15.75%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
14.85 22.04 -32.63% 19.01 -21.87%
ROE 18.55 17.13 8.28%
ROA 12.24 10.35 18.31%
ROIC 14.63 10.89 34.36%
ROS 14.44 11.8 22.37%
ROCE 14.59 18.81 -22.45%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.7048 1.25 -43.65% 0.8366 -15.76%
Nеt Debt/Ebitda 0.4406 1.05 -58.01%
Debt/Ratio 0.0779 0.1376 -43.35%
Debt/Equity 0.483 0.8085 -40.26%
Debt/Net Income 0.676 3.21 -78.95%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.58/10
1.03 12.08 -91.48% 1.1 -6.15%
Number of years of dividend growth 2 1.26 58.54%
DSI 0.8571 0.8404 1.99%
Average dividend growth -94.99 -66.15 43.6%
Average percentage for 5 years 1.1 11.32 -90.31%
Average percentage for payments 21.29 30.57 -30.36%
Difference from average difference in sector -11.05

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
6/10
49.07 87.3 -43.79%
Growth impulse Ebitda in 5 years 43.83 45.31 -3.27%
Growth impulse Net Income in 5 years 59.33 138.32 -57.11%
Growth impulse FCF in 5 years 660.75 82.83 697.72%
Growth impulse EPS in 5 years 59.33 288.08 -79.41%
IP Score
5.9/10

Similar companies

Apollo Hospitals Enterprise Limited

Torrent Pharmaceuticals Limited

Abbott India Limited

Cipla Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription